{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:03:58Z","timestamp":1792119838942,"version":"4.4.0"},"reference-count":143,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.drugalcdep.2012.11.013","type":"journal-article","created":{"date-parts":[[2013,1,8]],"date-time":"2013-01-08T17:24:41Z","timestamp":1357665881000},"page":"180-209","source":"Crossref","is-referenced-by-count":36,"title":["Tuberculosis, injecting drug use and integrated HIV-TB care: A review of the literature"],"prefix":"10.1016","volume":"129","author":[{"given":"Pippa","family":"Grenfell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Baptista Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Garfein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smiljka","family":"de Lussigny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Platt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Rhodes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0005","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.drugpo.2007.04.004","volume":"18","author":"Aceijas","year":"2007","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0010","first-page":"927","article-title":"Isoniazid preventive therapy for people living with HIV: public health challenges and implementation issues","volume":"13","author":"Ait-Khaled","year":"2009","journal-title":"Int. J. Tuberc. Lung. Dis."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0015","first-page":"1264","article-title":"Multi-drug resistant TB and HIV in Thailand: overlapping, but not independently associated risk factors","volume":"40","author":"Akksilp","year":"2009","journal-title":"Southeast Asian J. Trop. Med. Public Health"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0020","first-page":"6","article-title":"Relative frequency of infections among hospitalized injecting drug user \u2013 HIV positive patients in Razi hospital, Ahvaz, SW Iran (2001\u20132003)","volume":"1","author":"Alavi","year":"2008","journal-title":"Jundishapur J. Microbiol. (JJM)"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0025","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0140-6736(10)60829-X","article-title":"Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs","volume":"376","author":"Altice","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0030","first-page":"375","article-title":"Prevalence of tuberculosis and HIV infections among participants in an intravenous drug user risk-control program","volume":"73","author":"Alvarez Rodriguez","year":"1999","journal-title":"Rev. Esp. Salud Publ."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0035","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.1360-0443.2004.00812.x","article-title":"Changing profiles of injecting drug users with AIDS in a Hispanic population","volume":"99","author":"Amill","year":"2004","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0040","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1258\/0956462054679124","article-title":"Impact of an effective multidrug-resistant tuberculosis control programme in the setting of an immature HIV epidemic: system dynamics simulation model","volume":"16","author":"Atun","year":"2005","journal-title":"Int. J. STD AIDS"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0045","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.healthpol.2006.05.021","article-title":"Impact of joined-up HIV harm reduction and multidrug resistant tuberculosis control programmes in Estonia: system dynamics simulation model","volume":"81","author":"Atun","year":"2007","journal-title":"Health Policy"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0050","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1086\/590009","article-title":"Extensively drug-resistant tuberculosis in California, 1993\u20132006","volume":"47","author":"Banerjee","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0055","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0376-8716(01)00208-3","article-title":"A controlled trial of methadone treatment combined with directly observed isoniazid for tuberculosis prevention in injection drug users","volume":"66","author":"Batki","year":"2002","journal-title":"Drug. Alcohol. Depend."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0060","first-page":"988","article-title":"Yield of tuberculin screening among injection drug users","volume":"8","author":"Brassard","year":"2004","journal-title":"Int. J. Tuberc. Lung. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2012.11.013_bib0065","first-page":"42","article-title":"Harnessing peer networks as an instrument for AIDS prevention: results from a peer-driven intervention","volume":"113","author":"Broadhead","year":"1998","journal-title":"Public Health Rep."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0070","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0277-9536(01)00167-8","article-title":"Increasing drug users\u2019 adherence to HIV treatment: results of a peer-driven intervention feasibility study","volume":"55","author":"Broadhead","year":"2002","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0075","first-page":"632","article-title":"Correlation between mantoux and tuberculin's fraction from delayed hypersensitivity skin test, in a cohort from HIV-1 positive patients, in function of immunodeficiency level, and active tuberculosis incidence","volume":"17","author":"Cabarcos Ortiz de Barron","year":"2000","journal-title":"Ann. Med. Intern."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0080","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1157\/13096749","article-title":"Spanish cohort of naive HIV-infected patients (CoRIS): rationale, organization and initial results","volume":"25","author":"Caro-Murillo","year":"2007","journal-title":"Enferm. Infecc. Microbiol. Clin."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0085","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00002030-199509040-00010","article-title":"Sociodemographic predictors and temporal trends of extrapulmonary tuberculosis as an AIDS-defining disease in Spain","volume":"9","author":"Castilla","year":"1995","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0090","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1097\/00002030-199713000-00006","article-title":"Pulmonary and extrapulmonary tuberculosis at AIDS diagnosis in Spain: epidemiological differences and implications for control","volume":"11","author":"Castilla","year":"1997","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0095","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/ije\/24.6.1188","article-title":"Differential characteristics of AIDS patients with a history of imprisonment","volume":"24","author":"Cayla","year":"1995","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0100","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/1465-9921-10-121","article-title":"Tuberculosis treatment adherence and fatality in Spain","volume":"10","author":"Cayla","year":"2009","journal-title":"Respir. Res."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0105","first-page":"15","article-title":"Guidelines for using the QuantiFERON(R)-TB test for diagnosing latent Mycobacterium tuberculosis infection","volume":"52","author":"Centers for Disease Control and Prevention","year":"2003","journal-title":"MMWR"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0110","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0002-9343(01)00695-7","article-title":"A randomized, controlled trial of interventions to improve adherence to isoniazid therapy to prevent tuberculosis in injection drug users","volume":"110","author":"Chaisson","year":"2001","journal-title":"Am. J. Med."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0115","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1086\/319348","article-title":"Clinical presentation and risk behaviors of patients with acquired immunodeficiency syndrome in Thailand, 1994\u20131998: regional variation and temporal trends","volume":"32","author":"Chariyalertsak","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0120","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/00004836-200204000-00021","article-title":"Viral hepatitis and other infectious diseases in a homeless population","volume":"34","author":"Cheung","year":"2002","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0125","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1086\/514016","article-title":"Comparison of a tuberculin interferon-assay with the tuberculin skin test in high-risk adults: effect of human immunodeficiency virus infection","volume":"176","author":"Converse","year":"1997","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0130","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1365-2648.2007.04257.x","article-title":"The impact of social factors on tuberculosis management","volume":"58","author":"Craig","year":"2007","journal-title":"J. Adv. Nurs."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0135","series-title":"Building Integrated Care Services for Injection Drug Users in Ukraine","author":"Curtis","year":"2010"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0140","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1164\/ajrccm.157.1.9701111","article-title":"Incidence of tuberculosis in injection drug users in San Francisco: impact of anergy","volume":"157","author":"Daley","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0145","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1086\/594126","article-title":"Tuberculosis and illicit drug use: review and update","volume":"48","author":"Deiss","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0150","first-page":"122","article-title":"DOTS in drug addicts with TB: Delhi experience","volume":"55","author":"Dhingra","year":"2008","journal-title":"Indian J. Tuberc."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0155","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.puhe.2010.09.002","article-title":"Involving community partners in the management of tuberculosis among drug users","volume":"125","author":"Duarte","year":"2011","journal-title":"Public Health"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0160","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1046\/j.1360-0443.1998.939139310.x","article-title":"Risk factors for and knowledge of Mycobacterium tuberculosis infection among drug users in substance abuse treatment","volume":"93","author":"Durante","year":"1998","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0165","series-title":"HIV\/AIDS Surveillance in Europe 2010","author":"European Centre for Disease Prevention and Control\/WHO-Europe","year":"2011"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0170","first-page":"153","article-title":"Use of incentives to increase compliance for TB screening in a population of intravenous drug users. Vancouver Injection Drug Use Study Group","volume":"3","author":"FitzGerald","year":"1999","journal-title":"Int. J. Tuberc. Lung. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2012.11.013_bib0175","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1097\/QAI.0b013e3181f9c0b6","article-title":"Infectious disease comorbidities adversely affecting substance users with HIV: hepatitis C and tuberculosis","volume":"55","author":"Friedland","year":"2010","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2012.11.013_bib0180","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/QAI.0b013e31820bc9ba","article-title":"Integration of buprenorphine for substance-abuse treatment by HIV care providers","volume":"56","author":"Friedland","year":"2011","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2012.11.013_bib0185","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1086\/518664","article-title":"Implementation issues in tuberculosis\/HIV program collaboration and integration: 3 case studies","volume":"196","author":"Friedland","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0190","first-page":"S135","article-title":"Social determinants and the health of drug users: socioeconomic status, homelessness, and incarceration","volume":"117","author":"Galea","year":"2002","journal-title":"Public Health Rep."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0195","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/S0140-6736(10)60410-2","article-title":"Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis","volume":"375","author":"Gandhi","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0200","first-page":"626","article-title":"High prevalence of latent tuberculosis infection among injection drug users in Tijuana, Mexico","volume":"13","author":"Garfein","year":"2009","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0205","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3201\/eid1605.091446","article-title":"Latent tuberculosis among persons at risk for infection with HIV, Tijuana, Mexico","volume":"16","author":"Garfein","year":"2010","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0210","first-page":"703","article-title":"Barriers to successful tuberculosis treatment in Tomsk, Russian Federation: non-adherence, default and the acquisition of multidrug resistance","volume":"85","author":"Gelmanova","year":"2007","journal-title":"Bull. WHO"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0215","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/COH.0b013e328354bd44","article-title":"Tuberculosis and HIV in people who inject drugs: evidence for action for tuberculosis, HIV, prison and harm reduction services","volume":"7","author":"Getahun","year":"2012","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0220","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1086\/498315","article-title":"Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America","volume":"41","author":"Girardi","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0225","first-page":"205","article-title":"Incidence and risk factors of the association of AIDS and tuberculosis in Spain","volume":"110","author":"Godoy","year":"1998","journal-title":"Med. Clin."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0230","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/QAI.0b013e31818d5c1c","article-title":"Long-term effectiveness of diagnosing and treating latent tuberculosis infection in a cohort of HIV-infected and at-risk injection drug users","volume":"49","author":"Golub","year":"2008","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0235","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1300\/J069v15n01_07","article-title":"Successful adherence to observed prophylaxis and treatment of tuberculosis among drug users in a methadone program","volume":"15","author":"Gourevitch","year":"1996","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0240","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1097\/00002030-199910220-00009","article-title":"Effectiveness of isoniazid chemoprophylaxis for HIV-infected drug users at high risk for active tuberculosis","volume":"13","author":"Gourevitch","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0245","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1001\/archinte.1996.00440080089010","article-title":"Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease","volume":"156","author":"Graham","year":"1996","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0250","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/eurpub\/ckp009","article-title":"Vulnerability to drug-related infections and co-infections among injecting drug users in Budapest, Hungary","volume":"19","author":"Gyarmathy","year":"2009","journal-title":"Eur. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0255","series-title":"Website: Reports Section","author":"Harm Reduction International","year":"2011"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0260","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1001\/jama.300.4.423","article-title":"Opportunities and challenges for HIV care in overlapping HIV and TB epidemics","volume":"300","author":"Havlir","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0265","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1378\/chest.09-0394","article-title":"Latent TB infection treatment acceptance and completion in the United States and Canada","volume":"137","author":"Horsburgh","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0270","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1086\/343827","article-title":"Crack cocaine use and other risk factors for tuberculin positivity in drug users","volume":"35","author":"Howard","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0275","first-page":"140","article-title":"Influence of the human immunodeficiency virus in the incidence of tuberculosis in a cohort of intravenous drug users: effectiveness of anti-tuberculosis chemoprophylaxis","volume":"2","author":"Jansa","year":"1998","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0280","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/00042560-199607000-00010","article-title":"Tuberculosis among AIDS patients in the United States, 1993","volume":"12","author":"Jones","year":"1996","journal-title":"J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0285","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1086\/515593","article-title":"Trends in AIDS-related opportunistic infections among men who have sex with men and among injecting drug users, 1991\u20131996","volume":"178","author":"Jones","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0290","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.drugpo.2010.02.001","article-title":"Optimal provision of needle and syringe programmes for injecting drug users: a systematic review","volume":"21","author":"Jones","year":"2010","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0295","first-page":"215","article-title":"Directly observed treatment for tuberculosis in pharmacies compared with self-administered therapy in Spain","volume":"10","author":"Juan","year":"2006","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0300","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1086\/314707","article-title":"Comparison between a whole blood interferon-gamma release assay and tuberculin skin testing for the detection of tuberculosis infection among patients at risk for tuberculosis exposure","volume":"179","author":"Kimura","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0305","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1590\/S1135-57272003000500005","article-title":"Risk factors for tuberculous disease in AIDS cases reported in Brazil, from 1980 to 2000","volume":"77","author":"Laguardia","year":"2003","journal-title":"Rev. Esp. Salud Publ."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0310","series-title":"Opioid Substitution Therapy in Eurasia: How to Increase the Access and Improve the Quality","author":"Latypov","year":"2012"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0315","first-page":"200","article-title":"Seroprevalence of viral hepatitis and infectious complications among human immunodeficiency virus-infected injection drug users at a referral hospital","volume":"41","author":"Liang","year":"2008","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0320","first-page":"128","article-title":"Two-step tuberculin skin testing of injection drug users recruited from community-based settings","volume":"1","author":"Lifson","year":"1997","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0325","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/ije\/27.1.121","article-title":"Epidemiology of drug-resistant tuberculosis in New Jersey from 1991 to 1995","volume":"27","author":"Liu","year":"1998","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0330","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1016\/j.socscimed.2009.03.041","article-title":"Drivers of tuberculosis epidemics: the role of risk factors and social determinants","volume":"68","author":"Lonnroth","year":"2009","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0335","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/BF02351503","article-title":"Incentives and accessibility: a pilot study to promote adherence to TB prophylaxis in a high-risk community","volume":"76","author":"Lorvick","year":"1999","journal-title":"J. Urban Health"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0340","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/00002030-200203290-00012","article-title":"Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic","volume":"16","author":"Lucas","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0345","doi-asserted-by":"crossref","first-page":"792","DOI":"10.2105\/AJPH.88.5.792","article-title":"Tuberculosis screening and compliance with return for skin test reading among active drug users","volume":"88","author":"Malotte","year":"1998","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0350","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0749-3797(98)00093-2","article-title":"Monetary versus nonmonetary incentives for TB skin test reading among drug users","volume":"16","author":"Malotte","year":"1999","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0355","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0749-3797(00)00283-X","article-title":"Incentives vs outreach workers for latent tuberculosis treatment in drug users","volume":"20","author":"Malotte","year":"2001","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0360","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/infdis\/174.2.299","article-title":"The effect of latent Mycobacterium tuberculosis infection on human immunodeficiency virus (HIV) disease progression and HIV RNA load among injecting drug users","volume":"174","author":"Manoff","year":"1996","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0365","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1183\/09031936.98.12040967","article-title":"Predictors of adherence to tuberculosis treatment in a supervised therapy programme for prisoners before and after release","volume":"12","author":"Marco","year":"1998","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0370","doi-asserted-by":"crossref","first-page":"123","DOI":"10.7326\/0003-4819-126-2-199701150-00005","article-title":"Incidence of tuberculosis in the United States among HIV-infected persons. The Pulmonary Complications of HIV Infection Study Group","volume":"126","author":"Markowitz","year":"1997","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0375","first-page":"41","article-title":"Mycobacterium tuberculosis and human immunodeficiency virus co-infection in intravenous drug users on admission to prison","volume":"4","author":"Martin","year":"2000","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0380","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0140-6736(08)61311-2","article-title":"Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review","volume":"372","author":"Mathers","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0385","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1258\/0956462053057576","article-title":"Co-infection with HIV and TB: double trouble","volume":"16","author":"McShane","year":"2005","journal-title":"Int. J. STD AIDS"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0390","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ijid.2008.03.012","article-title":"High prevalence of multidrug-resistant tuberculosis in Georgia","volume":"12","author":"Mdivani","year":"2008","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0395","doi-asserted-by":"crossref","first-page":"340","DOI":"10.7326\/0003-4819-146-5-200703060-00006","article-title":"Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research","volume":"146","author":"Menzies","year":"2007","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0400","first-page":"8","article-title":"Appropriateness of antibiotic treatment in intravenous drug users, a retrospective analysis","author":"Mertz","year":"2008","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0405","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1097\/QAD.0b013e3282f1c933","article-title":"Changes in the incidence of tuberculosis in a cohort of HIV-seroconverters before and after the introduction of HAART","volume":"21","author":"Muga","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0410","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1046\/j.1360-0443.1999.947107112.x","article-title":"Tuberculosis chemoprophylaxis using a liquid isoniazid-methadone admixture for drug users in methadone maintenance","volume":"94","author":"O\u2019Connor","year":"1999","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0415","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1378\/chest.108.2.460","article-title":"Pulmonary complications associated with illicit drug use: an update","volume":"108","author":"O\u2019Donnell","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0420","series-title":"Website: Resource Center Publications and Articles","author":"Open Society Foundations","year":"2011"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0425","series-title":"Barriers to Access: Medication-assisted Treatment and Injection-driven HIV Epidemics","author":"Open Society Institute","year":"2008"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0430","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/00126334-200304150-00009","article-title":"Impaired virologic response to highly active antiretroviral therapy associated with ongoing injection drug use","volume":"32","author":"Palepu","year":"2003","journal-title":"J. Acquire. Immune Defic. Syndr."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0435","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.drugalcdep.2006.02.003","article-title":"Antiretroviral adherence and HIV treatment outcomes among HIV\/HCV co-infected injection drug users: the role of methadone maintenance therapy","volume":"84","author":"Palepu","year":"2006","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0440","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1360-0443.2009.02888.x","article-title":"Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews","volume":"105","author":"Palmateer","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0445","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0740-5472(97)00193-1","article-title":"Organizational issues in conducting tuberculosis screening at a syringe exchange program","volume":"15","author":"Paone","year":"1998","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0450","first-page":"862","article-title":"Tuberculosis screening at a syringe exchange program","volume":"87","author":"Perlman","year":"1997","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0455","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1093\/jurban\/78.3.550","article-title":"Cost-effectiveness of tuberculosis screening and observed preventive therapy for active drug injectors at a syringe-exchange program","volume":"78","author":"Perlman","year":"2001","journal-title":"J. Urban Health"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0460","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1093\/jurban\/jtg044","article-title":"Impact of monetary incentives on adherence to referral for screening chest X-rays after syringe exchange-based tuberculin skin testing","volume":"80","author":"Perlman","year":"2003","journal-title":"J. Urban Health"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0465","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/135562102200120460","article-title":"Tuberculin skin testing in intravenous drug users: differences between HIV-seropositive and HIV-seronegative subjects","volume":"7","author":"Portu","year":"2002","journal-title":"Addict. Biol."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0470","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/jurban\/79.1.113","article-title":"Characteristics of injection drug users who utilize tuberculosis services at sites of the Baltimore City Needle Cxchange Program","volume":"79","author":"Riley","year":"2002","journal-title":"J. Urban Health"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0475","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2105\/AJPH.94.7.1207","article-title":"HIV seroprevalence among homeless and marginally housed adults in San Francisco","volume":"94","author":"Robertson","year":"2004","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0480","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00042560-199804150-00014","article-title":"Risk behaviors, HIV seropositivity, and tuberculosis infection in injecting drug users who operate shooting galleries in Puerto Rico","volume":"17","author":"Robles","year":"1998","journal-title":"J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0485","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/00042560-199604150-00004","article-title":"Active tuberculosis in HIV-infected injecting drug users from a low-rate tuberculosis area","volume":"11","author":"Rubinstien","year":"1996","journal-title":"J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0490","first-page":"799","article-title":"Prevalence of Mycobacterium tuberculosis infection among injection drug users in Toronto","volume":"160","author":"Rusen","year":"1999","journal-title":"CMJ"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0495","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/1756-0500-4-192","article-title":"Enhanced tuberculosis case detection among substitution treatment patients: a randomized controlled trial","volume":"4","author":"Ruutel","year":"2011","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0500","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1086\/323896","article-title":"Isoniazid preventive therapy, hepatitis C virus infection, and hepatotoxicity among injection drug users infected with Mycobacterium tuberculosis","volume":"33","author":"Sadaphal","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0505","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0740-5472(98)00033-6","article-title":"Knowledge of tuberculosis among drug users. Relationship to return rates for tuberculosis screening at a syringe exchange","volume":"16","author":"Salomon","year":"1999","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0510","first-page":"47","article-title":"Prevalence and risk factors for positive tuberculin skin tests among active drug users at a syringe exchange program","volume":"4","author":"Salomon","year":"2000","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0515","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0376-8716(00)80010-1","article-title":"Drug abuse, methadone treatment, and health services use among injection drug users with AIDS","volume":"60","author":"Sambamoorthi","year":"2000","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0520","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1093\/ije\/24.3.630","article-title":"Predictive factors of Mycobacterium tuberculosis infection and pulmonary tuberculosis in prisoners","volume":"24","author":"Sanchez","year":"1995","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0525","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/1757177409354732","article-title":"Treatment of latent Mycobacterium tuberculosis infection in intravenous drug users co-infected with HIV","volume":"11","author":"Sanchez","year":"2010","journal-title":"J. Infect. Prevent."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0530","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1001\/archneur.1996.00550070109018","article-title":"Tuberculous meningitis: clinical characteristics and comparison with cryptococcal meningitis in patients with human immunodeficiency virus infection","volume":"53","author":"Sanchez-Portocarrero","year":"1996","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0535","series-title":"Delivery of Effective Tuberculosis Treatment to Drug Dependent HIV-positive Patients","author":"Sarang","year":"2011"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0540","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1086\/379513","article-title":"Effectiveness of isoniazid treatment for latent tuberculosis infection among human immunodeficiency virus (HIV)-infected and HIV-uninfected injection drug users in methadone programs","volume":"37","author":"Scholten","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0545","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0962-8479(05)80024-3","article-title":"Factors associated with extrapulmonary tuberculosis as an AIDS-defining disease in Europe","volume":"76","author":"Schwoebel","year":"1995","journal-title":"Tuberc. Lung Dis."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0550","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1258\/ijsa.2008.008299","article-title":"Drug abuse profile \u2013 patient delay, diagnosis delay and drug resistance pattern \u2013 among addict patients with tuberculosis","volume":"20","author":"Shamaei","year":"2009","journal-title":"Int. J. STD AIDS"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0555","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3923\/jms.2006.686.689","article-title":"Infection among hospitalized injection drug users","volume":"6","author":"Sharifi-Mood","year":"2006","journal-title":"J. Med. Sci."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0560","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1590\/S1806-37132006000100011","article-title":"Prevalence of and factors related to tuberculosis in seropositive human immunodeficiency virus patients at a reference center for treatment of human immunodeficiency virus in the southern region of the state of Rio Grande do Sul, Brazil","volume":"32","author":"Silveira","year":"2006","journal-title":"J. Bras. Pneumol."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0565","first-page":"2","article-title":"HIV and TB in practice in India: integrating TB\/HIV care and other essential health services into \u2018targeted interventions\u2019 for drug users","author":"Smart","year":"2010","journal-title":"HIV and AIDS Treat. Pract."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0570","first-page":"134","article-title":"Directly observed therapy in an inner city hospital","volume":"2","author":"Smirnoff","year":"1998","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0575","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1164\/ajrccm.160.1.9810082","article-title":"Tuberculosis prevention in methadone maintenance clinics. Effectiveness and cost-effectiveness","volume":"160","author":"Snyder","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0580","first-page":"447","article-title":"Comorbidities among HIV-infected injection drug users in Chennai, India","volume":"127","author":"Solomon","year":"2008","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0585","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1097\/00002030-199812000-00006","article-title":"Mycobacterium tuberculosis infection and disease are not associated with protection against subsequent disseminated M. avium complex disease","volume":"12","author":"Sterling","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0590","series-title":"Website: Resources Section","author":"Stop TB Partnership","year":"2011"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0595","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1164\/rccm.200802-251ED","article-title":"Predicting tuberculosis \u2013 does the IGRA tell the tale?","volume":"177","author":"Stout","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0600","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10096-008-0627-y","article-title":"Risk factors for multidrug-resistant tuberculosis in a tuberculosis unit in Madrid, Spain","volume":"28","author":"Suarez-Garcia","year":"2009","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0605","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1300\/J069v26n02_09","article-title":"Two-step tuberculin skin testing in drug users","volume":"26","author":"Swaminathan","year":"2007","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0610","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.drugpo.2007.03.001","article-title":"Integration and co-location of HIV\/AIDS, tuberculosis and drug treatment services","volume":"18","author":"Sylla","year":"2007","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0615","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/00126334-199908010-00011","article-title":"Clinical presentation of hospitalized adult patients with HIV infection and AIDS in Bangkok, Thailand","volume":"21","author":"Tansuphasawadikul","year":"1999","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0620","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00002030-199602000-00014","article-title":"Factors associated with tuberculosis at AIDS diagnosis in France","volume":"10","author":"Triol","year":"1996","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0625","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1758-2652-9-3-62","article-title":"Tuberculosis and HIV-needed: a new paradigm for the control and management of linked epidemics","volume":"9","author":"Tsiouris","year":"2007","journal-title":"J. Int. AIDS Soc."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0630","series-title":"Website: Publications Section","author":"United Nations Office on Drugs and Crime","year":"2011"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0635","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1365-3156.2012.02956.x","article-title":"Health system barriers to implementation of collaborative TB and HIV activities including prevention of mother to child transmission in South Africa","volume":"17","author":"Uwimana","year":"2012","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0640","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S1473-3099(11)70145-1","article-title":"Integrated delivery of HIV and tuberculosis services in sub-Saharan Africa: a systematic review","volume":"11","author":"Uyei","year":"2011","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0645","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/00002030-199704000-00014","article-title":"The spread of AIDS and the re-emergence of tuberculosis in Catalonia, Spain","volume":"11","author":"Vall Mayans","year":"1997","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0650","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/00002030-200305230-00012","article-title":"Tuberculosis risk varies with the duration of HIV infection: a prospective study of European drug users with known date of HIV seroconversion","volume":"17","author":"van Asten","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0655","first-page":"829","article-title":"Factors associated with positive tuberculin skin test results among HIV-infected persons in Orel Oblast, Russia","volume":"13","author":"Vitek","year":"2009","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0715","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2307\/800824","article-title":"Targeted sampling \u2013 options for the study of hidden populations","volume":"36","author":"Watters","year":"1989","journal-title":"Soc. Probl."},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0660","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(10)60832-X","article-title":"Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward","volume":"376","author":"Wolfe","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0665","series-title":"Treatment of Tuberculosis: Guidelines","author":"World Health Organization","year":"2006"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0670","series-title":"4. Management of Tuberculosis and HIV Coinfection: Clinical Protocol for the European Region","author":"World Health Organization","year":"2007"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0675","series-title":"Global Tuberculosis Control: Surveillance, Planning, Financing","author":"World Health Organization","year":"2008"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0680","series-title":"Policy Guidelines for Collaborative TB and HIV Services for Injecting and Other Drug Users: an Integrated Approach. Evidence For Action Technical Papers","author":"World Health Organization","year":"2009"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0685","series-title":"Global Tuberculosis Control 2010","author":"World Health Organization","year":"2010"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0690","series-title":"Global Tuberculosis Control Report 2011","author":"World Health Organization","year":"2011"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0695","series-title":"Guidelines for Intensified Tuberculosis Case-finding and Isoniazid Preventive Therapy for People Living with HIV in Resource-constrained Settings","author":"World Health Organization","year":"2011"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0700","series-title":"Priorities in Operational Research to Improve Tuberculosis Care and Control","author":"World Health Organization","year":"2011"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0705","series-title":"Website: Publications on Tuberculosis Section","author":"World Health Organization","year":"2011"},{"key":"10.1016\/j.drugalcdep.2012.11.013_bib0710","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1258\/0956462971919660","article-title":"A study of Malaysian drug addicts with human immunodeficiency virus infection","volume":"8","author":"Yoong","year":"1997","journal-title":"Int. J. STD AIDS"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871612004541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871612004541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,7]],"date-time":"2019-07-07T22:56:22Z","timestamp":1562540182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871612004541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":143,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0376871612004541"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2012.11.013","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}